Leaflet EZICLEN concentrate for oral solution


Indicated for: constipation

Route of administration: oral

Substance: sodium sulfate + magnesium sulfate + potassium sulfate (laxative + mineral)

ATC: A06AD10 (Alimentary tract and metabolism | Drugs for constipation | Osmotically acting laxatives)

Sodium sulfate, magnesium sulfate, and potassium sulfate are used together as a solution for bowel cleansing before medical procedures such as colonoscopy. This combination works by drawing water into the intestine, resulting in a complete evacuation of bowel contents.

The medication is taken orally, usually in the form of a solution, and should be used as directed by the doctor to ensure effective bowel cleansing. It is important to drink plenty of fluids during treatment to prevent dehydration.

Side effects may include nausea, bloating, abdominal cramps, or diarrhea. In rare cases, electrolyte imbalances or severe allergic reactions may occur, requiring immediate medical attention.

Patients should inform their doctor about any other medications being used or pre-existing conditions, such as kidney failure or electrolyte imbalances, as these may affect the safety of using this combination.

General data about EZICLEN

  • Substance: sodium sulfate + magnesium sulfate + potassium sulfate
  • Date of last drug list: 01-05-2026
  • Commercial code: W66207001
  • Pharmaceutical form: concentrate for oral solution
  • Quantity: 2
  • Product type: original
  • Price: 73.53 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: BEAUFOUR IPSEN INDUSTRIE - FRANTA
  • Holder: IPSEN CONSUMER HEALTHCARE - FRANTA
  • Number: 11040/2018/01
  • Shelf life: 3 years-after packing for marketing; after the first opening of the bottle-it is used immediately